BRIEF published on 02/16/2026 at 15:32, 3 months 15 days ago The Vanguard Group Discloses Position in Spire Healthcare The Vanguard Group Takeover Code Securities Disclosure Spire Healthcare Share Transactions
BRIEF published on 02/16/2026 at 15:32, 3 months 15 days ago The Vanguard Group Discloses Position in Oxford Biomedica Form 8.3 Takeover Code Securities Disclosure Vanguard Group Oxford Biomedica
PRESS RELEASE published on 02/16/2026 at 15:30, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses holding 5.07% in JTC plc. Form 8.3 filing under Rule 8.3 of Takeover Code. Transaction details of 1p ordinary shares included The Vanguard Group, Inc. Form 8.3 Takeover Code 1p Ordinary Shares JTC Plc
BRIEF published on 02/16/2026 at 15:30, 3 months 15 days ago The Vanguard Group Reports Significant Stake in Just Group plc Securities Disclosure Vanguard Group Inc. Shareholding Just Group Plc
PRESS RELEASE published on 02/16/2026 at 15:30, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses 1.24% stake in Bluefield Solar Income Fund Limited as of 13 Feb 2026. Public disclosure under Rule 8.3 of the Takeover Code The Vanguard Group Rule 8.3 Takeover Code Stake Disclosure Bluefield Solar Income Fund Limited
PRESS RELEASE published on 02/16/2026 at 15:29, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% ownership in Beazley plc through 30,130,743 5p ordinary shares as of 13 Feb 2026 The Vanguard Group Ownership Disclosure 5.03% Beazley Plc 30,130,743 Shares
BRIEF published on 02/16/2026 at 15:29, 3 months 15 days ago The Vanguard Group Discloses Major Holding in LondonMetric Property Form 8.3 The Vanguard Group Takeover Code Securities Disclosure LondonMetric Property
PRESS RELEASE published on 02/16/2026 at 15:28, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.51% interest in Schroders plc's 20p ordinary securities. Details in Form 8.3 filing Securities Form 8.3 Disclosure Schroders Plc Vanguard Group
BRIEF published on 02/16/2026 at 15:28, 3 months 15 days ago Vanguard Discloses Stake in International Personal Finance Form 8.3 The Vanguard Group Takeover Code Stake Disclosure International Personal Finance
PRESS RELEASE published on 02/16/2026 at 15:27, 3 months 15 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Details of securities holdings and recent dealings provided Securities Financial Dealings Vanguard Group Spire Healthcare Stake Disclosure
Published on 06/04/2026 at 14:45, 28 minutes ago Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
Published on 06/04/2026 at 14:30, 43 minutes ago Predictiv AI's Shift Technologies Secures Multi-Phase Commercial Contract to Digitize and Scale Middle-Mile and Last-Mile Logistics for Prompt Xpress
Published on 06/04/2026 at 14:00, 1 hour 13 minutes ago Horizon Aircraft Appoints Richard Alexander as Chief Engineer of Certified Programs
Published on 06/04/2026 at 14:00, 1 hour 13 minutes ago GameSquare Issues Shareholder Letter Highlighting Strong Second Quarter and Year-to-Date Momentum
Published on 06/04/2026 at 14:00, 1 hour 13 minutes ago EQ Works Expands ClearLake Platform with AI-Powered Audience Segments
Published on 06/04/2026 at 14:35, 37 minutes ago Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $437 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Over 283 Million WLD Tokens
Published on 06/04/2026 at 14:09, 1 hour 3 minutes ago Diginex Expands Supply Chain End-to-End Product Suite Amid Accelerating Regulatory Pressure
Published on 06/04/2026 at 13:35, 1 hour 37 minutes ago TCL Unveils Expanded Monitor Lineup in Europe, Including its First Flagship OLED+ Monitor
Published on 06/04/2026 at 13:15, 1 hour 57 minutes ago Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
Published on 06/04/2026 at 07:50, 7 hours 23 minutes ago Schneider Electric launches an offering of bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs) due 2034 for a nominal amount of €800 million and a concurrent repurchase of its outstanding OCEANEs due 2030 by way of a re
Published on 06/03/2026 at 18:02, 21 hours 10 minutes ago Information concerning the total number of voting rights and shares 2026 05 31
Published on 06/03/2026 at 17:45, 21 hours 28 minutes ago Manitou Group signs an amendment to its Sustainability Linked Loan (SLL) credit agreement to align its ESG criteria with its LIFT strategy
Published on 06/03/2026 at 17:45, 21 hours 28 minutes ago VOGO has won all lots in the National Rugby League’s latest call for tenders and has signed a strategic six-season partnership.
Published on 06/03/2026 at 17:45, 21 hours 28 minutes ago Report on share repurchases from 27 May to 2 June 2026
